BRK, Active
Recombinant full-length human BRK was expressed by baculovirus in Sf9 insect cells using a N-terminal GST tag.
Catalog No. P94-10G
| Catalog No. | Pack Size | Price (USD) | |
|---|---|---|---|
| P94-10G-05 | 5 ug | $226 | |
| P94-10G-10 | 10 ug | $325 | |
| P94-10G-BULK | BULK | Contact Us |
Recombinant full-length human BRK was expressed by baculovirus in Sf9 insect cells using a N-terminal GST tag.
Catalog No. P94-10G
| Catalog No. | Pack Size | Price (USD) | |
|---|---|---|---|
| P94-10G-05 | 5 ug | $226 | |
| P94-10G-10 | 10 ug | $325 | |
| P94-10G-BULK | BULK | Contact Us |
Overview:
BRK is a member of the non-receptor tyrosine kinases (PTKs) that contains an amino terminal SH3 and SH2 domain as well as the catalytic domain (1). BRK expression is low or undetectable in normal mammary tissue and benign lesions. However, approximately two-thirds of breast tumors express appreciable levels, and 27% of tumors over express BRK by fivefold or more (2).
Gene Aliases:
PTK6; FLJ42088
Genbank Number:
References:
1. Mitchell, PJ. et al: Cloning and characterisation of cDNAs encoding a novel non-receptor tyrosine kinase, brk, expressed in human breast tumours. Oncogene. 1994 Aug;9(8):2383-90.
2. Mitchell, PJ. et al: Characterisation and chromosome mapping of the human non receptor tyrosine kinase gene, brk. Oncogene. 1997 Sep 18;15(12):1497-502.Erratum in: Oncogene 1998 Jul 9;17(1):129.
Specific Activity:
Sample Kinase Activity Plot. For specific information on a given lot, see related technical data sheet.
|
Purity:
Sample Purity Data. For specific information on a given lot, see related technical data sheet.
|
Storage, Stability and Shipping:
Store product at –70oC. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles.
Molecular Weight:
~80 kDa
RK Goel et al., The unique N-terminal region of SRMS regulates enzymatic activity and phosphorylation of its novel substrate docking protein 1. FEBS Journal September 2013 10.1111/febs.12420
Miah Sayem et al., BRK Targets Dok1 for ubiquitin-mediated proteasomal degradation to promote cell proliferation and migration PLoS One February 2014 10.1371/journal.pone.0087684
et al., Mapping phospho-catalytic dependencies of therapy-resistant tumours reveals actionable vulnerabilities Nature cell biology April 2020
et al., Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants. Cancer cell February 2020
Cancer, Cytoplasmic Tyrosine Kinases
LCK, Active, L03-10G
FRK, Active, F14-11G
LYN A, Active, L13-18G
Poly (4:1 Glu, Tyr) Peptide, P61-58
STAY CONNECTED
Fax: 1-604-232-4601
Toll Free: 1-866-954-6273
info@signalchem.com